"A significant event": CBD-based pharma drug Epidiolex presented to FDA for approval
GW Pharmaceuticals, a.k.a. Greenwich Biosciences, has submitted to the FDA a New Drug Application for Epidiolex, a cannabis-based epilepsy drug with CBD.
Original Source: The Cannabist